NCSM

Analyst Note: NCS Multistage Holdings, Inc. (NCSM)

Date: 2026-06-13

1. Structural Readiness

Family: Coil State: Forming

• Conservative Entry: $54.55
• Current Price: $49.45
• Extension: -9.3% vs. conservative entry (Price is currently in a pullback relative to the breakout target).
• Breakout Level: $54.55 (The price must close above this level to transition from "Forming" to "Confirmed-Active").

2. Thesis Layer

Thesis Status: Tactical / Setup-Led. Macro Context: There is no named secular thesis attached to NCSM as of this date. The investment case is not driven by a specific macro narrative (e.g., "Energy Transition" or "Global Supply Shock") but is strictly setup-led. The conviction must be derived entirely from the quality of the technical structure (the Coil formation) and the underlying business fundamentals (revenue growth, margin expansion, and balance sheet strength) as reported by management. Do not invent a macro thesis; judge the name on its ability to execute its stated operational plan and the structural readiness of the chart.

3. Business Overview

Company: NCS Multistage Holdings, Inc. (NCSM) Industry: Energy Services / Oil & Gas Equipment Business Model: NCSM provides engineered products and support services for well construction, completion, and field development. The company operates through a single reportable segment, selling complementary products and services to Exploration and Production (E&P) companies globally.

Key Operations & Evidence (as of 2026-06-13):

• Product Portfolio: The company offers fracturing systems (including casing-installed sliding sleeves, subsurface frac isolation assemblies, and sand jet perforating tools), repeat precision products, well construction materials, and tracer diagnostics.
• *Evidence:* [E24], [E25], [E26]
• Revenue Composition: In 2025, approximately 60% of revenue was derived from fracturing systems and enhanced oil recovery systems, 20% from Repeat Precision, and 10% each from well construction products and tracer diagnostics.
• *Evidence:* [E17]
• Recent Growth & Acquisitions: The company acquired Reservoir Metrics, LLC (ResMetrics) on July 31, 2025, for $7.1 million to expand tracer diagnostics capabilities. ResMetrics contributed $1.8 million in revenue and a $0.2 million loss in the first quarter of 2026.
• *Evidence:* [E12], [E13], [E22]
• Financial Performance:
• Revenue: $183.6 million for the year ended Dec 31, 2025 (up from $162.6 million in 2024).
• Net Income: $23.7 million for 2025 (up from $6.6 million in 2024).
• *Evidence:* [E18], [E19]
• Management Guidance (Recorded as of March 5, 2026):
• Full Year 2026 Revenue: Expected range of $184 million to $194 million.
• Full Year 2026 Adjusted EBITDA: Expected range of $26 million to $29 million.
• Free Cash Flow: Expected to be $12 million to $16 million after distributions to JV partners.
• Seasonality: Management anticipates EBITDA achievement will be weighted toward the second half of the year, with free cash flow weighted toward year-end.
• *Evidence:* [E1], [E2], [E3]
• Geographic Expansion:
• North Sea: Received orders from two new customers in the Dutch sector in 2026.
• Gulf of America: First installation of Raytec Propex sliding sleeve system with integrated screen technology expected later in 2026.
• Middle East: First well utilizing fracturing systems technology completed in 2025; further applications expected in 2026.
• *Evidence:* [E5], [E6], [E7]
• Legal Context: A patent dispute regarding Kobold's patent claims was remitted to the trial court in October 2025 for reconsideration of invalidity (double patenting), with a hearing scheduled for September 2026.
• *Evidence:* [E16]

4. Archetype and Conviction Analysis

Archetype: Cyclical Recovery. Rationale: The company fits the "Cyclical Recovery" archetype based on the sharp improvement in profitability (Net Income rising from $6.6M to $23.7M) and revenue growth ($162.6M to $183.6M) in 2025, coupled with management's guidance for continued EBITDA expansion in 2026. The business is leveraging a recovering upstream environment to deploy new technologies (Raytec, ResMetrics) into emerging markets (Middle East, North Sea).

Valuation & Structural Quality:

• Financial Spine: Forward consensus EPS for FY1 is $3.415 and FY2 is $4.31.
• *Evidence:* [E28]
• ATR Analysis:
• ATR at Breakout: 4.9% (High). This indicates the structural quality at the setup level was historically strong, suggesting a robust move potential if the breakout occurs.
• Conviction Stack:
• Thesis Strength: Low (Tactical only, no macro tailwind).
• Evidence Quality: High (Strong earnings growth, clear guidance, successful M&A integration).
• Structural Quality: Moderate (ATR at breakout was high, but current ATR is extreme).
• Setup Readiness: Partial (Forming coil, price below entry, waiting for confirmation).
• Rerating Potential: Moderate (Dependent on successful execution of 2026 guidance and expansion into new geographies).

5. Invalidations, Strengths, and Gaps

What Would Invalidate the Case:

• Fundamental: A significant miss on the 2026 guidance (Revenue < $184M or EBITDA < $26M) or a failure to generate the projected $12M-$16M in free cash flow.
• Legal: An adverse ruling in the September 2026 Kobold patent hearing that results in a permanent injunction or significant damages.

What Would Strengthen the Case:

• Technical: A decisive daily close above the conservative entry of $54.55, transitioning the setup to "Confirmed-Active."
• Fundamental: Confirmation of the new customer orders in the North Sea and the successful deployment of the Raytec system in the Gulf of America as scheduled.
• Operational: Successful integration of ResMetrics leading to margin accretion in the second half of 2026.

Gaps in Evidence:

• Customer Concentration: While the top 5 customers account for 33% of revenue, specific details on the creditworthiness or long-term contract terms of these new international customers (Dutch North Sea, Middle East) are not detailed in the provided evidence.
• ResMetrics Profitability: ResMetrics contributed a loss of $0.2 million in Q1 2026. There is no explicit guidance on when this subsidiary is expected to become accretive to net income.
• Debt Maturity: The ABL Facility matures in May 2027. While management expects to renew it, the specific terms of the renewal or the impact of interest rates on the facility are not detailed.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key risks: Current ATR is extreme (9.2%), indicating high volatility and potential for deeper drawdown before breakout; Setup is still "Forming" and not yet confirmed; Legal uncertainty regarding Kobold patent hearing in September 2026; Customer concentration risk with top 5 clients. Sizing hint: Position size should be reduced relative to a confirmed breakout due to the extreme ATR and unconfirmed status; treat as a watchlist candidate for a confirmed close above $54.55. Expected path: Management expects revenue and EBITDA to grow in H2 2026 due to seasonality; successful deployment of new technologies in Gulf of America and Middle East should drive top-line growth; technical structure requires a breakout above $54.55 to confirm the setup. Expected horizon: 3 to 6 months for the setup to resolve (breakout or invalidation).